 | • レポートコード：MRC2203A836 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査資料では、世界の家庭用薬物乱用（DOA）検査市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、種類別（検査カップ、検査ストリップ、その他）分析、検体別（唾液、尿、血液、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来の傾向などの項目を掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の家庭用薬物乱用（DOA）検査市場規模：種類別（検査カップ、検査ストリップ、その他） ・世界の家庭用薬物乱用（DOA）検査市場規模：検体別（唾液、尿、血液、その他） ・世界の家庭用薬物乱用（DOA）検査市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Abbott、Dragerwerk AG & Co. KGaA、UCP Biosciences Inc.、...） ・市場機会・将来の傾向 |
The surge in the number of people who consume alcohol and illicit drugs such as marijuana, cocaine, and others, is one of the major drivers for market growth. Developed countries such as the United States have stringent laws for drug abuse and have mandated alcohol and drug testing to take legal action against addicts and abusers for the sake of limiting violence or accidents. Furthermore, the increasing overdose of prescription drugs and the diagnosis of these drugs and their metabolites is boosting the at-home drug of abuse testing market. According to the National Survey on Drug Use and Health (NSDUH), 19.7 million American adults engaged in a substance use disorder in 2017. However, lack of awareness of these testing devices is a constraint to the market growth.
Key Market Trends
Analysis of Urine is Expected to be the Dominant Segment by Sample Type Over the Forecast Period.
The dominant share of the segment is attributed to the advantages of drug of abuse testing using a urine sample. Detection through urine sample is the easiest and most affordable way, both illegal and prescription drugs can be checked for. The major advantage of the test is that the analysis can determine if specific drugs are used in the past few days or weeks, even after the effects of the drugs have worn off. Apart from the advantages the increasing drug consumption and increasing need to check the drug levels at home is boosting the segment growth. In 2018, there were an estimated 34.1 million young adults who suffered from both a mental health disorder and a substance use disorder or co-occurring disorders as per American Addiction Center. With this huge number of people suffering the segment and the market is tend to grow at a higher rate in the forecast period.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall market, throughout the forecast period. The dominant position of the market in this region is mainly due to a high number of people who are suffering from substance abuse or alcohol addiction. According to American Addiction Centers almost 74% of adults suffering from a substance use disorder in 2017 struggled with an alcohol use disorder. About 38% of adults in 2017 battled an illicit drug use disorder and 1 out of every 8 adults struggled with both alcohol and drug use disorders simultaneously. The high contribution due to the adaptation of technologically advanced products for drug abuse testing, increased demand for illicit drugs in the region, large scale drug trafficking, that is being responsible for the growth of the market.
Competitive Landscape
The At-Home Drug of Abuse (DOA) Testing Market is moderately competitive with several major players. Some of the major players are Abbott, Dragerwerk AG & Co. KGaA, UCP Biosciences Inc., Orient New Life Medical Co. Ltd., Assure Tech.(Hangzhou) Co., LTD, Psychemedics Corporation.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Use and Production of Illicit Drugs
4.2.2 Increasing Initiatives by Governemnt Organizations to Reduce Drug Abuse
4.3 Market Restraints
4.3.1 Lack of Awareness and Consideration of Drug Testing
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Test Cups
5.1.2 Test Strips
5.1.3 Others
5.2 By Sample Type
5.2.1 Saliva
5.2.2 Urine
5.2.3 Blood
5.2.4 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott
6.1.2 Dragerwerk AG & Co. KGaA
6.1.3 UCP Biosciences Inc.
6.1.4 Orient New Life Medical Co. Ltd.
6.1.5 Assure Tech.(Hangzhou) Co., LTD
6.1.6 Psychemedics Corporation
6.1.7 CONFIRM BIOSCIENCES
6.1.8 Phamatech Inc.
6.1.9 Home Health (UK) Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS